[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337305-105":59,"doc-detail-337305-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mutation-spectrum-analysis-of-brca12-genes-for-hereditary-breast-and-ovarian-cancer-in-the-indian-population","Mutation Spectrum Analysis of BRCA1/2 Genes for Hereditary Breast and Ovarian Cancer in the Indian Population","","This retrospective cohort study assessed the prevalence and mutation spectrum of BRCA1/2 variants associated with hereditary breast and ovarian cancer (HBOC) in an Indian population. Data from 500 patients meeting NCCN criteria underwent BRCA1/2 testing between 2017 and 2023 using next-generation sequencing with positive calls confirmed by Sanger sequencing. Overall BRCA positivity was 23.8%, with specific rates of pathogenic, likely pathogenic, and VUS variants, and results were analyzed by age, sex, and personal and family history.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mutation-spectrum-analysis-of-brca12-genes-for-hereditary-breast-and-ovarian-cancer-in-the-indian-population/337305/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mutation-spectrum-analysis-of-brca12-genes-for-hereditary-breast-and-ovarian-cancer-in-the-indian-population/337305.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the primary objective of the study?","Question",{"text":112,"@type":113},"To determine the prevalence and mutation spectrum of BRCA-linked genetic mutations for hereditary breast and ovarian cancer in the Indian population, and to evaluate correlations with age, gender, and personal/family history.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were BRCA mutations detected and validated?",{"text":117,"@type":113},"BRCA1/2 testing used next-generation sequencing on the Thermo Ion GeneStudio S5 system, and positive mutations were confirmed with Sanger sequencing.",{"name":119,"@type":110,"acceptedAnswer":120},"What proportion of patients showed BRCA positivity, and what correlations were observed?",{"text":121,"@type":113},"BRCA positivity was found in 23.8% of patients. The study reported a statistically significant correlation between BRCA mutations and patient and family history.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337305,1790380936,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","RESEARCH ARTICLE  \nEditorial Process: Submission:03/09/2024 Acceptance:12/13/2024  \nMutation Spectrum Analysis of BRCA1/2 Genes for Hereditary Breast and Ovarian Cancer in the Indian Population  \nKunjal Lila, Harshita Bhanushali, Milind Chanekar, Raj Jatale, Monisha Banerjee, Rakhi Bajpai Dixit, Aparna Rajadhyaksha, Kirti Chadha*  \nAbstract  \nObjective: The objective of this study was to determine the prevalence and spectrum of genetic mutations linked to inherited breast and ovary cancer (HBOC) in the Indian population, and to evaluate the correlation of BRCA mutation types, frequency, and incidence with age, gender, and personal and family history. Methods: A retrospective cohort of 500 Indian HBOCpatients, meeting NCCN criteria who underwent BRCA1/2 testing from 2017 to 2023 were shortlisted for this study. The anonymized data was retrieved from medical records. Genetic analysis was conducted using Next Generation Sequencing (NGS) on the Thermo Ion GeneStudio™ S5 System, with positive mutations confirmed via Sanger sequencing. Peripheral blood samples were processed for DNA extraction, library preparation, and variant classification following ACMG guidelines. Results: Out of the 500 patients, 119 (23.8%) were positive for BRCA mutations, and 381 (76.2%) were negative. The prevalence of BRCA pathogenesis, likely pathogenicity, and variants of uncertain significance (VUSs) were 14.8%, 1.6%, and 7.4%, respectively. A total of 128 mutations were detected in the positive BRCA1/2 patients. A statistically significant correlation was found between BRCA mutations with the patient and family history. A total of 38.8% of the patients with mutations had a family history of BC, OC or BC/OC, while 7.6% had other cancers. BRCA mutations were predominant (26.2%) in the age group of 46-65 Y. Among the 128 mutations, 59.3%(76/128) and 40.6%(52/12) of the patients had mutations in BRCA1 and BRCA2, respectively. Missense mutations were the most common in both the BRCA1 (30.26%) and BRCA2 (55.77%) genes, followed by frameshift (22.3%) and nonsense (17.3%) mutations in BRCA1 and BRCA2, respectively. Conclusion: BRCA positivity was detected in 23.8% of the patients. A statistically significant association was shown between BRCA mutations and patient and family history.  \nKeywords: Next generation sequencing-developing countries-breast cancer-ovarian cancer  \nAsian Pac J Cancer Prev, 25 (12), 4145-4151  \nIntroduction  \nBreast cancer (BC) is the most common cancer among women worldwide. BC is responsible for approximately 11.6% of all cancer cases and 6.6% of all cancer-related deaths (Bray et al. 2018) . Ovarian cancer (OC) is less common than breast cancer and accounts for approximately 1.6% of all cancers and 1.9% of cancer-related deaths [1] . Approximately 90–95% of breast cancers and 80% of ovarian tumors are sporadic, while 5–10% and 20% are familial or hereditary, respectively. Among BC/ OC cases, 20–25% are caused by the highly penetrant cancer susceptibility genes BRCA1 and BRCA2 [2] . BRCA1/2 mutations are found in different ethnic groups and geographical locations, with frequencies in white European and Australian populations (17.6–29.8%) and lower frequencies in Asian countries (9.4–21.7%) [3]. The frequency of breast cancer in Asian countries, specifically  \nIndia, is lower than that in developed countries because of the large population size. However, the number of deaths from new cases reported in India is much greater (48.3%) than that in the United States (18.9%) and European Union (25.4%) [4] . Delayed implementation of effective breast cancer screening programs, lifestyle changes, and limited access to treatment are reasons cited for higher mortality rates in India [5] . It is critical to identify high-risk populations and provide them with timely genetic consultation to determine risk, mutation carrier status, genetic variation analysis, preventive care, and prophylactic surgery for reducing mortality.  \nNext-generation sequen","cbCaikSrOdfTVSiT","https://ap.wps.com/l/cbCaikSrOdfTVSiT","pdf",524067,"English","# Abstract\n# Introduction\n# Materials and Methods","[{\"question\":\"What was the primary objective of the study?\",\"answer\":\"To determine the prevalence and mutation spectrum of BRCA-linked genetic mutations for hereditary breast and ovarian cancer in the Indian population, and to evaluate correlations with age, gender, and personal/family history.\"},{\"question\":\"How were BRCA mutations detected and validated?\",\"answer\":\"BRCA1/2 testing used next-generation sequencing on the Thermo Ion GeneStudio S5 system, and positive mutations were confirmed with Sanger sequencing.\"},{\"question\":\"What proportion of patients showed BRCA positivity, and what correlations were observed?\",\"answer\":\"BRCA positivity was found in 23.8% of patients. The study reported a statistically significant correlation between BRCA mutations and patient and family history.\"}]","Mutation Spectrum Analysis of BRCA1/2 Genes for Hereditary Breast and Ovarian Cancer in the Indian Population | PDF",1790018530,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b52bbde25f9b4b8b9172d402bb2703a.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08b278c77361021e44a48636534c446e.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9af1a0f16462b806d99c52ed352cfbb2.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0726967e1219262b0e127504101d5509.webp",980,1385]